Tc Biopharm Is A Clinical Stage Cell Therapy Company Based In The Ukpublicly Traded On Nasdaq Under The Ticker Tcbpfounded In 2014The Company Has Expanded To Five Global Locations And Employs Over 100 Peopletc Biopharm Specializes In Developing Innovative Cell Based Immunotherapiesfocusing On Advanced Allogeneic Car T Cell Therapy Products And Gamma Delta T Cell Therapies For Cancer And Infectious Diseases The Company S Flagship Productomnimmuneis Part Of A Broader Portfolio Aimed At Treating Various Cancers And Infectious Diseasestc Biopharm Utilizes A Proprietary Allogeneic Technology Platform To Create Therapies That Leverage The Body S Immune Cells To Target Diseased Tissuetheir Clinical Programs Primarily Address Unmet Needs In Oncologyparticularly For Acute Myeloid Leukemia And Other Hematological Malignancieswhile Also Exploring Applications For Viral Infectionsthe Company S Mission Is To Enhance Patient Health And Quality Of Life Through The Development And Commercialization Of Innovative Cell Based Products
